RMFCX
Price
$54.97
Change
+$0.24 (+0.44%)
Updated
Dec 23 closing price
VGICX
Price
$68.03
Change
+$0.82 (+1.22%)
Updated
Dec 20 closing price
Ad is loading...

RMFCX vs VGICX

Header iconRMFCX vs VGICX Comparison
Open Charts RMFCX vs VGICXBanner chart's image
American Funds American Mutual R3
Price$54.97
Change+$0.24 (+0.44%)
VolumeN/A
CapitalizationN/A
JPMorgan US Value C
Price$68.03
Change+$0.82 (+1.22%)
VolumeN/A
CapitalizationN/A
RMFCX vs VGICX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMFCX vs. VGICX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Buy and VGICX is a Sell.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 102B vs. VGICX (6.01B). RMFCX pays higher dividends than VGICX: RMFCX (1.69) vs VGICX (1.04). RMFCX was incepted earlier than VGICX: RMFCX (23 years) vs VGICX (27 years). VGICX is a more actively managed with annual turnover of: 59.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than VGICX: RMFCX (250) vs VGICX (1000). VGICX annual gain was more profitable for investors over the last year : 13.27 vs. RMFCX (11.11). VGICX return over 5 years is better than : 47.90 vs. RMFCX (37.80).
RMFCXVGICXRMFCX / VGICX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years27 years-
Gain YTD9.92112.30981%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets102B6.01B1,697%
Annual Yield % from dividends1.691.04163%
Returns for 1 year11.1113.2784%
Returns for 3 years12.3819.5863%
Returns for 5 years37.8047.9079%
Returns for 10 years59.3671.0284%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QURE16.981.51
+9.76%
uniQure NV
HAYW15.440.10
+0.65%
Hayward Holdings
TER125.950.76
+0.61%
Teradyne
ISPO3.36-0.06
-1.75%
Inspirato
ADCT1.96-0.16
-7.55%
ADC Therapeutics SA